BGMSHIGH SIGNALFINANCIAL10-K

BGMS underwent a dramatic financial turnaround with stockholders' equity swinging from -$2.2M to +$6.8M while simultaneously experiencing a massive 96.6% reduction in outstanding shares from 207M to 5.5M shares.

The combination of achieving positive stockholders' equity and the extreme share count reduction (likely through a reverse stock split or major buyback) suggests either a significant recapitalization event or potential going concern resolution. The dramatic reduction in current liabilities from $6.3M to $1.3M indicates either debt restructuring or settlement of major obligations, which would explain the improved equity position.

Comparing 2026-03-30 vs 2025-04-02View on EDGAR →
FINANCIAL ANALYSIS

BGMS experienced a comprehensive financial transformation with total assets doubling to $8.2M while current liabilities plummeted 78.7% to $1.3M, enabling the shift from negative to positive stockholders' equity of $6.8M. Operating performance improved significantly with R&D expenses cut by 87.3% and net losses reduced from -$11.2M to -$3.0M, while operating cash flow burn decreased 40.3% to -$4.8M. The extreme 96.6% reduction in share count alongside these improvements suggests a major recapitalization or restructuring event that has fundamentally altered the company's financial profile.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+414.7%
-$2.2M$6.8M

Equity base grew 414.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+99.9%
$4.1M$8.2M

Asset base grew 99.9% — expansion through organic growth, acquisitions, or capital deployment.

R&D Expense
P&L
-87.3%
$6.7M$848K

R&D spending cut 87.3% — could signal cost discipline or concerning reduction in innovation investment.

Current Liabilities
Balance Sheet
-78.7%
$6.3M$1.3M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
-78.6%
$6.3M$1.3M

Liabilities reduced 78.6% — deleveraging improves balance sheet strength and financial flexibility.

Net Income
P&L
+73.3%
-$11.2M-$3.0M

Net income grew 73.3% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
+70.3%
$3.7M$6.3M

Current assets grew 70.3% — improving short-term liquidity or inventory/receivables build.

Operating Cash Flow
Cash Flow
+40.3%
-$8.0M-$4.8M

Operating cash flow surged 40.3% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+29.8%
-$12.0M-$8.4M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

SG&A Expense
P&L
-19.7%
$6.7M$5.4M

SG&A reduced 19.7% — improved cost efficiency or headcount reduction improving operating margins.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-04-02
ADDED
Employer of Incorporation or Organization) Identification No.) Level 10, Tower 11 , Avenue 5, No.
7262(b)) by the registered public accounting firm that prepared or issued its audit report.
As of March 24, 2026, there were 5,519,456 shares of the registrant s common stock outstanding.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 93 Item 13.
Below is a summary of the principal risk factors that may affect our business, financial condition and results of operations.
+7 more — sign up free →
REMOVED
Cyclacel Pharmaceuticals, Inc._December 31, 2024 0001130166 false 2024 FY Cyclacel Pharmaceuticals, Inc.
Employer Identification No.) Level 10, Tower 11 , Avenue 5, No.
7262(b)) by the registered public accounting firm that prepared or issued its audit report .
As of March 27, 2025, there were 207,336,389 shares of the registrant s common stock outstanding.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 116 I tem 13.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →